GSA CAPITAL PARTNERS LLP Stoke Therapeutics, Inc. Transaction History

GSA CAPITAL PARTNERS LLP portfolio value:

$965,000
portfolio value

Stoke Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 75.12K shares 965K $12.84 75.12K
Q2 2022 share Decrease -100.00% -40.49K shares -852K $13.21 0
Q1 2022 share Increase +65.51% 16.02K shares 265K $21.05 40.49K
Q4 2021 share Increase +150.87% 14.71K shares 339K $24.07 24.46K
Q3 2021 share Increase 0.00% 9.75K shares 248K $25.44 9.75K